Pembrolizumab with trastuzumab and chemotherapy for untreated locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction adenocarcinoma
Technology appraisal guidance
Reference number: TA983
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.